Corcept Therapeutics Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Corcept Therapeutics · Common stock · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Corcept Therapeutics
- Product or service
- Common stock
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Corcept Securities Fraud Lawsuit Intake
Participation information
Availability is based on each listed participation option and its deadline.
Corcept Securities Fraud Lawsuit Intake
Purchasers of Corcept common stock between October 31, 2024 and December 30, 2025, inclusive, were invited to contact Rosen Law Firm regarding the class action.
Submit information through the Rosen Law Firm form or contact the firm for information about the class action.
- Type
- Law Firm Signup
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Corcept Therapeutics Securities Fraud Class Action
Barchart.com ·